Brief: Themis Medicare Announces DCGI Approval Of Remifentanil Hydrochloride 1Mg/2Mg
17/02/2023 05:24
Feb 17 (Reuters) - Themis Medicare Ltd THEM.NS :
* THEMIS MEDICARE LTD - ANNOUNCES DCGI APPROVAL OF
REMIFENTANIL
HYDROCHLORIDE 1MG/2MG
* THEMIS MEDICARE LTD - DCGI APPROVAL FOR IMPORT AND
MARKETING OF
REMIFENTANIL HYDROCHLORIDE
Source text for Eikon: ID:nNSE2d6C0n
Further company coverage: THEM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Themis Medicare
See all newsBrief: Themis Medicare Gets Tax Demand Of 41.8 Million Rupees
Brief: Themis Medicare Announces Amalgamation Of Gujarat Themis Biosyn With Co
India's Themis Medicare hits record high on Q1 profit jump
Brief: Themis Medicare June-Qtr Consol Net Profit 246.8 Mln Rupees
India's Themis Medicare hits record high